Literature DB >> 3767147

Reversible cold-induced abnormalities in myocardial perfusion and function in systemic sclerosis.

E L Alexander, G S Firestein, J L Weiss, R R Heuser, G Leitl, H N Wagner, J A Brinker, A A Ciuffo, L C Becker.   

Abstract

The effects of peripheral cold exposure on myocardial perfusion and function were studied in 13 patients with scleroderma without clinically evident myocardial disease. Ten patients had at least one transient, cold-induced, myocardial perfusion defect visualized by thallium-201 scintigraphy, and 12 had reversible, cold-induced, segmental left ventricular hypokinesis by two-dimensional echocardiography. The 10 patients with transient perfusion defects all had anatomically corresponding ventricular wall motion abnormalities. No one in either of two control groups (9 normal volunteers and 7 patients with chest pain and normal coronary arteriograms) had cold-induced abnormalities. This study is the first to show the simultaneous occurrence of cold-induced abnormalities in myocardial perfusion and function in patients with scleroderma. The results suggest that cold exposure in such patients may elicit transient reflex coronary vasoconstriction resulting in reversible myocardial ischemia and dysfunction. Chronic recurrent episodes of coronary spasm may lead to focal myocardial fibrosis.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3767147     DOI: 10.7326/0003-4819-105-5-661

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  23 in total

1.  Absence of epicardial coronary stenosis in patients with systemic sclerosis with severe impairment of coronary flow reserve.

Authors:  A Vacca; P Siotto; A Cauli; R Montisci; P Garau; V Ibba; A Mameli; G Passiu; S Iliceto; A Mathieu
Journal:  Ann Rheum Dis       Date:  2006-02       Impact factor: 19.103

2.  Acute myocardial infarction in systemic sclerosis patients: a case series.

Authors:  Chris T Derk; Sergio A Jimenez
Journal:  Clin Rheumatol       Date:  2006-03-07       Impact factor: 2.980

Review 3.  My approach to the treatment of scleroderma.

Authors:  Ami A Shah; Fredrick M Wigley
Journal:  Mayo Clin Proc       Date:  2013-04       Impact factor: 7.616

4.  Heart involvement in systemic sclerosis: a combined echocardiographic and scintigraphic study.

Authors:  Charalampos Papagoras; Kerstin Achenbach; Niki Tsifetaki; Spyridon Tsiouris; Andreas Fotopoulos; Alexandros A Drosos
Journal:  Clin Rheumatol       Date:  2014-05-22       Impact factor: 2.980

5.  Diastolic abnormalities in systemic sclerosis: evidence for associated defective cardiac functional reserve.

Authors:  G Valentini; D F Vitale; A Giunta; S Maione; G Gerundo; M Arnese; E Tirri; N Pelaggi; A Giacummo; G Tirri; M Condorelli
Journal:  Ann Rheum Dis       Date:  1996-07       Impact factor: 19.103

6.  Critical tissue ischaemia in scleroderma: a note of caution.

Authors:  J R Seibold
Journal:  Ann Rheum Dis       Date:  1994-05       Impact factor: 19.103

7.  Pulmonary vasospasm in systemic sclerosis: noninvasive techniques for detection.

Authors:  Gregory J Keir; Arjun Nair; Stamatia Giannarou; Guang-Zhong Yang; Paul Oldershaw; S John Wort; Peter MacDonald; David M Hansell; Athol U Wells
Journal:  Pulm Circ       Date:  2015-09       Impact factor: 3.017

8.  Replacement myocardial fibrosis at the site of late gadolinium enhancement on magnetic resonance imaging in a patient with diffuse cutaneous systemic sclerosis: An autopsy report.

Authors:  Atsushi Noguchi; Ichizo Tsujino; Noriko Oyama-Manabe; Mishie Tanino
Journal:  J Cardiol Cases       Date:  2017-05-13

9.  The effects of peripheral cold exposure on oesophageal motility in patients with autoimmune rheumatic diseases and Raynaud's phenomenon.

Authors:  E V Tsianos; C Berecos; E Stavropoulos; E Kazazis; I C Danielides; A A Drosos
Journal:  Clin Rheumatol       Date:  1991-09       Impact factor: 2.980

Review 10.  Clinical aspects of systemic sclerosis (scleroderma).

Authors:  R M Silver
Journal:  Ann Rheum Dis       Date:  1991-11       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.